Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29

Cited In for PubMed (Select 16510479)

1.

Ecstasy exposure & gender: examining components of verbal memory functioning.

Price JS, Shear P, Lisdahl KM.

PLoS One. 2014 Dec 29;9(12):e115645. doi: 10.1371/journal.pone.0115645. eCollection 2014.

2.

Meta-analysis of molecular imaging of serotonin transporters in major depression.

Gryglewski G, Lanzenberger R, Kranz GS, Cumming P.

J Cereb Blood Flow Metab. 2014 Jul;34(7):1096-103. doi: 10.1038/jcbfm.2014.82. Epub 2014 May 7.

3.

3,4-methylenedioxymethamphetamine (MDMA): current perspectives.

Meyer JS.

Subst Abuse Rehabil. 2013 Nov 21;4:83-99. doi: 10.2147/SAR.S37258. eCollection 2013. Review.

4.

Perspectives on zebrafish models of hallucinogenic drugs and related psychotropic compounds.

Neelkantan N, Mikhaylova A, Stewart AM, Arnold R, Gjeloshi V, Kondaveeti D, Poudel MK, Kalueff AV.

ACS Chem Neurosci. 2013 Aug 21;4(8):1137-50. doi: 10.1021/cn400090q. Epub 2013 Aug 6. Review.

5.

Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study.

Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Martin SF, Yazar-Klosinski B, Michel Y, Brewerton TD, Doblin R.

J Psychopharmacol. 2013 Jan;27(1):28-39. doi: 10.1177/0269881112456611. Epub 2012 Nov 20.

6.

Persistent Psychosis After a Single Ingestion of "Ecstasy" (MDMA).

Patel A, Moreland T, Haq F, Siddiqui F, Mikul M, Qadir H, Raza S.

Prim Care Companion CNS Disord. 2011;13(6). pii: PCC.11l01200. doi: 10.4088/PCC.11l01200. No abstract available.

7.

Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907.

Urban NB, Girgis RR, Talbot PS, Kegeles LS, Xu X, Frankle WG, Hart CL, Slifstein M, Abi-Dargham A, Laruelle M.

Neuropsychopharmacology. 2012 May;37(6):1465-73. doi: 10.1038/npp.2011.332. Epub 2012 Feb 22.

8.

Relationship between personality disorder dimensions and verbal memory functioning in a community population.

Park S, Hong JP, Lee HB, Samuels J, Bienvenu OJ, Chung HY, Eaton WW, Costa PT Jr, Nestadt G.

Psychiatry Res. 2012 Mar 30;196(1):109-14. doi: 10.1016/j.psychres.2011.08.012. Epub 2012 Feb 16.

9.

Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users.

Di Iorio CR, Watkins TJ, Dietrich MS, Cao A, Blackford JU, Rogers B, Ansari MS, Baldwin RM, Li R, Kessler RM, Salomon RM, Benningfield M, Cowan RL.

Arch Gen Psychiatry. 2012 Apr;69(4):399-409. doi: 10.1001/archgenpsychiatry.2011.156. Epub 2011 Dec 5.

10.

The influence of genetic and environmental factors among MDMA users in cognitive performance.

Cuyàs E, Verdejo-García A, Fagundo AB, Khymenets O, Rodríguez J, Cuenca A, de Sola Llopis S, Langohr K, Peña-Casanova J, Torrens M, Martín-Santos R, Farré M, de la Torre R.

PLoS One. 2011;6(11):e27206. doi: 10.1371/journal.pone.0027206. Epub 2011 Nov 16.

11.

Addiction and cognition.

Gould TJ.

Addict Sci Clin Pract. 2010 Dec;5(2):4-14. Review.

12.

Neuroimaging and drug taking in primates.

Murnane KS, Howell LL.

Psychopharmacology (Berl). 2011 Jul;216(2):153-71. doi: 10.1007/s00213-011-2222-7. Epub 2011 Mar 1. Review.

13.

Evidence of neurotoxicity of ecstasy: sustained effects on electroencephalographic activity in polydrug users.

Adamaszek M, Khaw AV, Buck U, Andresen B, Thomasius R.

PLoS One. 2010 Nov 23;5(11):e14097. doi: 10.1371/journal.pone.0014097.

14.

MDMA administration decreases serotonin but not N-acetylaspartate in the rat brain.

Perrine SA, Ghoddoussi F, Michaels MS, Hyde EM, Kuhn DM, Galloway MP.

Neurotoxicology. 2010 Dec;31(6):654-61. doi: 10.1016/j.neuro.2010.08.005. Epub 2010 Aug 26.

15.

Sleep apnea in young abstinent recreational MDMA ("ecstasy") consumers.

McCann UD, Sgambati FP, Schwartz AR, Ricaurte GA.

Neurology. 2009 Dec 8;73(23):2011-7. doi: 10.1212/WNL.0b013e3181c51a62. Epub 2009 Dec 2.

16.

During pregnancy, recreational drug-using women stop taking ecstasy (3,4-methylenedioxy-N-methylamphetamine) and reduce alcohol consumption, but continue to smoke tobacco and cannabis: initial findings from the Development and Infancy Study.

Moore DG, Turner JD, Parrott AC, Goodwin JE, Fulton SE, Min MO, Fox HC, Braddick FM, Axelsson EL, Lynch S, Ribeiro H, Frostick CJ, Singer LT.

J Psychopharmacol. 2010 Sep;24(9):1403-10. doi: 10.1177/0269881109348165. Epub 2009 Nov 25.

17.

Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA).

Baumann MH, Rothman RB.

Int Rev Neurobiol. 2009;88:257-96. doi: 10.1016/S0074-7742(09)88010-0.

18.

Cortisol and 3,4-methylenedioxymethamphetamine: neurohormonal aspects of bioenergetic stress in ecstasy users.

Parrott AC.

Neuropsychobiology. 2009;60(3-4):148-58. doi: 10.1159/000253551. Epub 2009 Nov 5. Review.

19.

Sleep deprivation differentially impairs cognitive performance in abstinent methylenedioxymethamphetamine ("Ecstasy") users.

McCann UD, Wilson MJ, Sgambati FP, Ricaurte GA.

J Neurosci. 2009 Nov 4;29(44):14050-6. doi: 10.1523/JNEUROSCI.4654-09.2009.

20.

The variety of ecstasy/MDMA users: results from the National Epidemiologic Survey on alcohol and related conditions.

Wu LT, Parrott AC, Ringwalt CL, Yang C, Blazer DG.

Am J Addict. 2009 Nov-Dec;18(6):452-61. doi: 10.3109/10550490903206049.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk